[Diagnosing Fauci’s Book](https://wbbsec.com/opinions-and-features/diagnosing-faucis-book-on-call-a-doctors-journey-in-public-service/)
[Diagnosing Fauci’s Book](https://wbbsec.com/opinions-and-features/diagnosing-faucis-book-on-call-a-doctors-journey-in-public-service/)
In: Press Releases

For Immediate Release

January 6, 2021

Cranford, NJ – Steve Brozak, Managing Partner and President of WBB Securities, LLC will moderate a live forum at Biotech Showcase on January 6, 2021 that will review options for COVID-19 Therapeutics.  Participants in the forum will be two distinguished experts in the biotechnology/pharmaceutical development industry.  They are Prabhavathi Fernandes, Ph.D. – Chair, National Biodefense Science Board and Michael Kurilla, M.D., Ph.D. – Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health.  The forum will begin at 10:00 am Pacific Time; 1:00 pm Eastern Time

About WBB Securities.

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily in the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer and is a member of the Financial Regulatory Authority, as well as a state registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high net-worth clients.


About Biotech Showcase – Investors Conference.

Biotech Showcase™ Digital, and its family of events, is an investor conference devoted to providing private and micro-mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives.  Featuring over 400 curated presenting companies from around the world, from seed-stage companies to public, multi-national companies, from platform technology to therapeutic areas to digital health and device and diagnostics, the event attract investors representing over USD 400 Billion in capital, and highly motivated strategic partners in the life science ecosystem.

We are committed to serving the life sciences industry during these challenging times by providing a way for our industry to connect when face-to-face meetings are not possible. Biotech Showcase will be delivered digitally January 11-15, 2021 on partneringONE®. This digital event solution will deliver all the value you would expect at a physical event!